A dietary supplement containing Chlorophytum borivilianum and Velvet bean improves sleep quality in men and women

Integrative Medicine Insights

Volumn 2012, Issue 7, 2012, Pages 7-14

  McCarthy, Cameron G ^a   Alleman, Rick J ^a   Bell, Zach W ^a   Bloomer, Richard J ^a  

^a UNIVERSITY OF MEMPHIS   (United States)

Author keywords

Chlorophytum borivilianum; Dietary supplements; Sleep; Velvet bean

Indexed keywords

HERBACEOUS AGENT;

ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD PRESSURE MEASUREMENT; CHLOROPHYTUM BORIVILIANUM; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DRUG CAPSULE; DRUG EFFECT; DRUG SAFETY; FEMALE; HEART RATE; HUMAN; MALE; OUTCOME ASSESSMENT; PITTSBURGH SLEEP QUALITY INDEX; PLANT ROOT; QUESTIONNAIRE; SLEEP DISORDER; SLEEP QUALITY; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; VELVET BEAN;

EID: 84865848725     PISSN: None     EISSN: 11773936     Source Type: Journal    
DOI: 10.4137/IMI.S9720     Document Type: Article

References (41)

1. Colten HR, Abboud FM, Block GD, et al. Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem (Brief Report). 2006; 2011.
2. Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep. 1999;22 Suppl 2:S386-93.
3. Sassani A, Findley LJ, Kryger M, Goldlust E, George C, Davidson TM. Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep. 2004;27:453-8.
4. IMS Health. Top Therapeutic Classes by Prescriptions. 2010;2011.
5. McCoy JG, Strecker RE. The cognitive cost of sleep lost. Neurobiol Learn Mem. 2011.
6. Faraut B, Boudjeltia KZ, Vanhamme L, Kerkhofs M. Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Med Rev. 2011.
7. Aldabal L, Bahammam AS. Metabolic, endocrine, and immune consequences of sleep deprivation. Open Respir Med J. 2011;5:31-43.
8. Kim HJ, Kim JH, Park KD, Choi KG, Lee HW. A survey of sleep deprivation patterns and their effects on cognitive functions of residents and interns in Korea. Sleep Med. 2011;12:390-6.
9. Roth T, Soubrane C, Titeux L, Walsh JK; Zoladult Study Group. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia. Sleep Med. 2006;7:397-406.
10. Meolie AL, Rosen C, Kristo D, et al. Oral nonprescription treatment for insomnia: an evaluation of products with limited evidence. J Clin Sleep Med. 2005;1:173-87.
11. Salter S, Brownie S. Treating primary insomnia-the efficacy of valerian and hops. Aust Fam Physician. 2010;39:433-7.
12. Gyllenhaal C, Merritt SL, Peterson SD, Block KI, Gochenour T. Efficacy and safety of herbal stimulants and sedatives in sleep disorders. Sleep Med Rev. 2000;4:229-51.
13. Centers for Disease Control and Prevention (CDC). Hepatic toxicity possibly associated with kava-containing products-United States, Germany, and Switzerland, 1999-2002. MMWR Morb Mortal Wkly Rep. 2002;51:1065-7.
14. Turek FW, Gillette MU. Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists. Sleep Med. 2004;5:523-32.
15. Rogers NL, Dinges DF, Kennaway DJ, Dawson D. Potential action of melatonin in insomnia. Sleep. 2003;26:1058-9.
16. Peterfi Z, McGinty D, Sarai E, Szymusiak R. Growth hormone-releasing hormone activates sleep regulatory neurons of the rat preoptic hypothalamus. Am J Physiol Regul Integr Comp Physiol. 2010;298:R147-56.
17. Kerkhofs M, Van Cauter E, Van Onderbergen A, Caufriez A, Thorner MO, Copinschi G. Sleep-promoting effects of growth hormone-releasing hormone in normal men. Am J Physiol. 1993;264:E594-8.
18. Obal FJr, Krueger JM. GHRH and sleep. Sleep Med Rev. 2004;8:367-77.
19. Thakur GS, Bag M, Sanodiya BS, et al. Chlorophytum borivilianum: a white gold for biopharmaceuticals and neutraceuticals. Curr Pharm Biotechnol. 2009;10:650-6.
20. Alleman RJJ, Canale RE, McCarthy CG, Bloomer RJ. A blend of Chlorophytum borivilianum and Velvet bean increases serum growth hormone in exercise-trained men. Nutrition and Metabolic Insights. 2011;4:55-63.
21. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193-213.
22. Miller FG, Colloca L, Kaptchuk TJ. The placebo effect: illness and interpersonal healing. Perspect Biol Med. 2009;52:518-39.
23. Pelsser LM, Frankena K, Buitelaar JK, Rommelse NN. Effects of food on physical and sleep complaints in children with ADHD: a randomised controlled pilot study. Eur J Pediatr. 2010;169:1129-38.
24. Pugalenthi M, Vadivel V, Siddhuraju P. Alternative food/feed perspectives of an underutilized legume Mucuna pruriens var. utilis-a review. Plant Foods Hum Nutr. 2005;60:201-18.
25. Kansal PC, Buse J, Talbert OR, Buse MG. The effect of L-dopa on plasma growth hormone, insulin, and thyroxine. J Clin Endocrinol Metab. 1972;34:99-105.
26. Boyd AE 3rd, Lebovitz HE, Pfeiffer JB. Stimulation of human-growth- hormone secretion by L-dopa. N Engl J Med. 1970;283:1425-9.
27. Lin T, Tucci JR. Provocative tests of growth-hormone release. A comparison of results with seven stimuli. Ann Intern Med. 1974;80:464-9.
28. Weldon VV, Gupta SK, Haymond MW, Pagliara AS, Jacobs LS, Daughaday WH. The use of L-DOPA in the diagnosis of hyposomatotropism in children. J Clin Endocrinol Metab. 1973;36:42-6.
29. Eddy RL, Jones AL, Chakmakjian ZH, Silverthorne MC. Effect of levodopa (L-DOPA) on human hypophyseal tropic hormone release. J Clin Endocrinol Metab. 1971;33:709-12.
30. Hayek A, Crawford JD. L-DOPA and pituitary hormone secretion. J Clin Endocrinol Metab. 1972;34:764-6.
31. Kerkhofs M, Van Cauter E, Van Onderbergen A, Caufriez A, Thorner MO, Copinschi G. Sleep-promoting effects of growth hormone-releasing hormone in normal men. Am J Physiol. 1993;264:E594-8.
32. Thakur M, Bhargava S, Praznik W, Loeppert R, Dixit VK. Effect of Chlorophytum Borivilianum Santapau and Fernandes on sexual dysfunction in hyperglycemic male rats. Chin J Integr Med. 2009;15:448-53.
33. Kenjale R, Shah R, Sathaye S. Effects of Chlorophytum borivilianum on sexual behaviour and sperm count in male rats. Phytother Res. 2008;22:796-801.
34. Dolev Z. Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy. Arch Womens Ment Health. 2011;14:269-73.
35. Kaynak H, Kaynak D, Gozukirmizi E, Guilleminault C. The effects of trazodone on sleep in patients treated with stimulant antidepressants. Sleep Med. 2004;5:15-20.
36. Wiegand MH, Galanakis P, Schreiner R. Nefazodone in primary insomnia: an open pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:1071-8.
37. Sabbatini M, Crispo A, Pisani A, et al. Zaleplon improves sleep quality in maintenance hemodialysis patients. Nephron Clin Pract. 2003;94:c99-103.
38. Pollack MH, Hoge EA, Worthington JJ, et al. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2011;72: 892-7.
39. Gooneratne NS, Gehrman P, Gurubhagavatula I, Al-Shehabi E, Marie E, Schwab R. Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study. J Clin Sleep Med. 2010;6:572-80.
40. Spira AP, Beaudreau SA, Stone KL, et al. Reliability and validity of the pittsburgh sleep quality index and the epworth sleepiness scale in older men. J Gerontol A Biol Sci Med Sci. 2011.
41. Fratello F, Curcio G, Ferrara M, et al. Can an inert sleeping pill affect sleep? Effects on polysomnographic, behavioral and subjective measures. Psychopharmacology (Berl). 2005;181:761-70.